These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38385427)

  • 21. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    Chang HH; Lee NY; Ko WC; Lee HC; Yang YH; Wu CJ; Chang CM
    Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Clotrimazole Fungal Prophylaxis on Tacrolimus Exposure in Kidney Transplant Recipients: A Retrospective Study.
    El-Sayed A; Vidal J; Khanmoradi K; Knorr JP
    Transplant Proc; 2021 Jun; 53(5):1583-1588. PubMed ID: 33962777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus (FK506) malabsorption: management with fluconazole coadministration.
    Dhawan A; Tredger JM; North-Lewis PJ; Gonde CE; Mowat AP; Heaton NJ
    Transpl Int; 1997; 10(4):331-4. PubMed ID: 9249946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium.
    Jacobson PA; Oetting WS; Brearley AM; Leduc R; Guan W; Schladt D; Matas AJ; Lamba V; Julian BA; Mannon RB; Israni A;
    Transplantation; 2011 Feb; 91(3):300-8. PubMed ID: 21206424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clotrimazole increases tacrolimus blood levels: a drug interaction in kidney transplant patients.
    Vasquez E; Pollak R; Benedetti E
    Clin Transplant; 2001 Apr; 15(2):95-9. PubMed ID: 11264634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential elevation of tacrolimus trough concentrations with concomitant metronidazole therapy.
    Page RL; Klem PM; Rogers C
    Ann Pharmacother; 2005 Jun; 39(6):1109-13. PubMed ID: 15855244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients.
    Wings E; Spinner M; Eckardt J
    Transpl Infect Dis; 2022 Aug; 24(4):e13882. PubMed ID: 35689488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.
    Gruessner RW; Bartlett ST; Burke GW; Stock PG
    Clin Transplant; 1998 Jun; 12(3):260-2. PubMed ID: 9642520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J; Mendez R; Pirsch JD; Jensik SC
    Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal allograft dysfunction associated with rifampin-tacrolimus interaction.
    Chenhsu RY; Loong CC; Chou MH; Lin MF; Yang WC
    Ann Pharmacother; 2000 Jan; 34(1):27-31. PubMed ID: 10669182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
    Zhu J; Campagne O; Torrice CD; Flynn G; Miller JA; Patel T; Suzuki O; Ptachcinski JR; Armistead PM; Wiltshire T; Mager DE; Weiner DL; Crona DJ
    Clin Transl Sci; 2021 May; 14(3):908-918. PubMed ID: 33502111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
    Elamin S; El-Magzoub AR; Dablouk N; Mahmoud F; Abbas M
    Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):814-8. PubMed ID: 24969193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between tacrolimus and chloramphenicol in a renal transplant recipient.
    Schulman SL; Shaw LM; Jabs K; Leonard MB; Brayman KL
    Transplantation; 1998 May; 65(10):1397-8. PubMed ID: 9625026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: effect of post-transplantation period.
    Ben Fredj N; Chaabane A; Chadly Z; Hammouda M; Aloui S; Boughattas NA; Skhiri H; Aouam K
    Transpl Immunol; 2013 Jun; 28(4):198-202. PubMed ID: 23608723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Low-Dose Fluconazole on Tacrolimus Dosing in Renal Transplant.
    Johnston JP; Cohen EA; Casal GH; Asch WS; Reardon DP
    J Pharm Pract; 2022 Oct; 35(5):701-706. PubMed ID: 33759619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function.
    Momper JD; Ridenour TA; Schonder KS; Shapiro R; Humar A; Venkataramanan R
    Am J Transplant; 2011 Sep; 11(9):1861-7. PubMed ID: 21714845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
    Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG
    World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation.
    Yaowakulpatana K; Vadcharavivad S; Ingsathit A; Areepium N; Kantachuvesiri S; Phakdeekitcharoen B; Sukasem C; Sra-Ium S; Sumethkul V; Kitiyakara C
    Eur J Clin Pharmacol; 2016 Mar; 72(3):277-83. PubMed ID: 26635230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H; Jeffery J; Sitar DS; Aoki FY
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.